| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 7.338 | 5.253 | 4.759 | 1.690 | 2.855 |
| Total Income - EUR | - | - | 0 | 0 | 0 | 11.581 | 11.477 | 12.776 | 19.331 | 9.044 |
| Total Expenses - EUR | - | - | 69 | 134 | 622 | 7.713 | 8.573 | 10.686 | 17.254 | 15.968 |
| Gross Profit/Loss - EUR | - | - | -69 | -134 | -622 | 3.868 | 2.903 | 2.090 | 2.077 | -6.924 |
| Net Profit/Loss - EUR | - | - | -69 | -134 | -622 | 3.758 | 2.819 | 1.968 | 2.060 | -6.953 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Biopont Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 33.550 | 32.900 | 32.151 | 24.598 | 21.556 | 13.961 | 8.083 |
| Current Assets | - | - | 34.818 | 1.214 | 1.351 | 1.372 | 4.844 | 14.197 | 6.211 | 470 |
| Inventories | - | - | 0 | 1.195 | 1.347 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 51 | 15 | 0 | 0 |
| Cash | - | - | 34.818 | 18 | 4 | 1.372 | 4.793 | 14.182 | 6.211 | 470 |
| Shareholders Funds | - | - | -25 | -158 | -777 | 2.996 | 5.748 | 7.734 | 9.771 | 2.763 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 66 | 783 | 1.703 | 2.073 | 2.037 | 540 | 701 | 2.143 |
| Income in Advance | - | - | 34.777 | 34.139 | 33.478 | 28.600 | 21.743 | 27.615 | 9.890 | 3.646 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9329 - 9329" | |||||||||
| CAEN Financial Year |
7721
|
|||||||||
Comments - Biopont Srl